2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC).

PubWeight™: 5.75‹?› | Rank: Top 1%

🔗 View Article (PMID 25173340)

Published in Eur Heart J on August 29, 2014

Authors

Raimund Erbel, Victor Aboyans, Catherine Boileau, Eduardo Bossone, Roberto Di Bartolomeo, Holger Eggebrecht, Arturo Evangelista, Volkmar Falk, Herbert Frank, Oliver Gaemperli, Martin Grabenwöger, Axel Haverich, Bernard Iung, Athanasios John Manolis, Folkert Meijboom, Christoph A Nienaber, Marco Roffi, Hervé Rousseau, Udo Sechtem, Per Anton Sirnes, Regula S von Allmen, Christiaan J M Vrints, ESC Committee for Practice Guidelines

Associated clinical trials:

Biomechanical Reappraisal of Planning for Thoracic Endovascular Aortic Repair (MALAN) | NCT03824626

Genetic Profile in Patients With Aortic Syndrome (GEN-AOR) | NCT04751058

Campania Registry On Peripheral Artery Disease (CARE-PAD) | NCT04903912

Articles citing this

(truncated to the top 100)

Aortic Dissection in Patients With Bicuspid Aortic Valve-Associated Aneurysms. Ann Thorac Surg (2015) 1.44

Cardiac surgery 2014 reviewed. Clin Res Cardiol (2015) 1.42

Modified transesophageal echocardiography of the dissected thoracic aorta; a novel diagnostic approach. Cardiovasc Ultrasound (2016) 1.39

Clinical utility gene card for: Hereditary thoracic aortic aneurysm and dissection including next-generation sequencing-based approaches. Eur J Hum Genet (2015) 1.18

Evaluation of the safety and efficacy of transcatheter aortic valve implantation in patients with a severe stenotic bicuspid aortic valve in a Chinese population. J Zhejiang Univ Sci B (2015) 0.94

Large vessel involvement by IgG4-related disease. Medicine (Baltimore) (2016) 0.92

Contemporary Management Strategies for Chronic Type B Aortic Dissections: A Systematic Review. PLoS One (2016) 0.86

Time-dependent changes of plasma inflammatory biomarkers in type A aortic dissection patients without optimal medical management. J Cardiothorac Surg (2015) 0.85

Feasibility and accuracy of bedside transthoracic echocardiography in diagnosis of acute proximal aortic dissection. Cardiovasc Ultrasound (2015) 0.84

NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice. Eur Heart J (2015) 0.84

Guilt by association: a paradigm for detection of silent aortic disease. Ann Cardiothorac Surg (2016) 0.84

Analysis of Strengths, Weaknesses, Opportunities, and Threats as a Tool for Translating Evidence into Individualized Medical Strategies (I-SWOT). Aorta (Stamford) (2015) 0.84

Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology. J Cardiovasc Magn Reson (2016) 0.83

Re-intervention after thoracic endovascular aortic repair is high, but we should keep optimistic. J Thorac Dis (2017) 0.81

Year in review: bicuspid aortopathy. Curr Opin Cardiol (2016) 0.81

Analysis of early and long-term outcomes of acute type A aortic dissection according to the new international aortic arch surgery study group recommendations. Heart Vessels (2015) 0.80

MDCT evaluation of acute aortic syndrome (AAS). Br J Radiol (2016) 0.80

Three-dimensional rotational angiography in children with an aortic coarctation. Neth Heart J (2016) 0.80

Prevalence of previously undiagnosed abdominal aortic aneurysms in the area of Como: the ComoCuore "looking for AAA" ultrasonography screening. Int J Cardiovasc Imaging (2016) 0.80

Four-dimensional flow magnetic resonance imaging-based characterization of aortic morphometry and haemodynamics: impact of age, aortic diameter, and valve morphology. Eur Heart J Cardiovasc Imaging (2015) 0.80

Gene panel sequencing in heritable thoracic aortic disorders and related entities - results of comprehensive testing in a cohort of 264 patients. Orphanet J Rare Dis (2015) 0.79

Computed tomography angiography of aorta subjected to external wrapping. J Cardiothorac Surg (2016) 0.79

Aortic Measurements in Patients with Aortopathy are Larger and More Reproducible by Cardiac Magnetic Resonance Compared with Echocardiography. Pediatr Cardiol (2015) 0.79

Non-invasive volumetric assessment of aortic atheroma: a core laboratory validation using computed tomography angiography. Int J Cardiovasc Imaging (2015) 0.78

Aortic emergencies-diagnosis and treatment: a pictorial review. Insights Imaging (2015) 0.78

Differential expression of microRNAs in aortic tissue and plasma in patients with acute aortic dissection. J Geriatr Cardiol (2015) 0.78

Single center experience with wrapping of the dilated ascending aorta. J Cardiothorac Surg (2015) 0.78

Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model. Arterioscler Thromb Vasc Biol (2016) 0.78

Does This Study Make My Aorta Look Fat? Circulation (2015) 0.77

Case report of an endovascular repair of a residual type A dissection using a not CE not FDA-approved Najuta thoracic stent graft system. Medicine (Baltimore) (2015) 0.77

Epidemiology and Medication Utilization Pattern of Aortic Dissection in Taiwan: A Population-Based Study. Medicine (Baltimore) (2015) 0.77

Type 2 Diabetes Mellitus and Thoracic Aortic Aneurysm and Dissection: An Observational Population-Based Study in Spain From 2001 to 2012. Medicine (Baltimore) (2016) 0.77

Evaluation of myocardial strain and artery elasticity using speckle tracking echocardiography and high-resolution ultrasound in patients with bicuspid aortic valve. Int J Cardiovasc Imaging (2016) 0.76

Quality markers in cardiology: measures of outcomes and clinical practice-a perspective of the Spanish Society of Cardiology and of Thoracic and Cardiovascular Surgery. Eur Heart J (2015) 0.76

Prognostic value of (18)F-fluorodeoxyglucose PET-CT imaging in acute aortic syndromes: comparison with serological biomarkers of inflammation. Int J Cardiovasc Imaging (2015) 0.76

Comparison of Hemodynamics After Aortic Root Replacement Using Valve-Sparing or Bioprosthetic Valved Conduit. Ann Thorac Surg (2015) 0.75

Plasma Lactate Dehydrogenase Levels Predict Mortality in Acute Aortic Syndromes: A Diagnostic Accuracy and Observational Outcome Study. Medicine (Baltimore) (2016) 0.75

Treatment of acute thoracic aortic syndromes using endovascular techniques. Diagn Interv Radiol (2016) 0.75

Admission white blood cell count predicts short-term clinical outcomes in patients with uncomplicated Stanford type B acute aortic dissection. J Geriatr Cardiol (2017) 0.75

Postoperative glucocorticoid enhances recovery after endovascular aortic repair for chronic type B aortic dissection: a single-center experience. BMC Cardiovasc Disord (2016) 0.75

Rare Case of Vaginal Delivery in Giant Aortic Aneurysm. Aorta (Stamford) (2015) 0.75

Blunt Thoracic Aortic Injuries: New Perspectives in Management. Open Cardiovasc Med J (2015) 0.75

Comments on the 2014 ESC guidelines on the diagnosis and treatment of aortic diseases. Rev Esp Cardiol (Engl Ed) (2015) 0.75

Equivocal usefulness of FDG for the noninvasive imaging of abdominal aortic aneurysms. Eur J Nucl Med Mol Imaging (2014) 0.75

Evaluation of the Aortic Arch from the Suprasternal Notch View Using Focused Cardiac Ultrasound. J Emerg Med (2016) 0.75

Modern diagnostics for type B aortic dissection. Gefasschirurgie (2015) 0.75

Chronic Thoracic Aortic Aneurysm Presenting 29 Years following Trauma. Case Rep Surg (2015) 0.75

Prognostic Impact of Blood Pressure Variability on Aortic Dissection Patients After Endovascular Therapy. Medicine (Baltimore) (2015) 0.75

Re-interventions after TEVAR for type B aortic dissection: considerations for management and the need for further insight. J Thorac Dis (2016) 0.75

Clinical and echocardiographic determinants in bicuspid aortic dilatation: Results from a longitudinal observational study. Medicine (Baltimore) (2016) 0.75

Aorto-esophageal fistula: the multi-disciplinary team approach to management. Clin Case Rep (2016) 0.75

Cross-sectional imaging of aortic infections. Insights Imaging (2016) 0.75

Transcatheter aortic valve implantation for Chinese patients with bicuspid aortic valve. J Zhejiang Univ Sci B (2015) 0.75

Dual-phase CT for the assessment of acute vascular injuries in high-energy blunt trauma: the imaging findings and management implications. Br J Radiol (2016) 0.75

MRI in Chronic Aortic Dissection: A Systematic Review and Future Directions. Front Cardiovasc Med (2015) 0.75

Fenestrated and Branched Aortic Grafts. Dtsch Arztebl Int (2015) 0.75

International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations: Results of the Montalcino Aortic Consortium. Circ Cardiovasc Genet (2016) 0.75

Estimating the irreversible pressure drop across a stenosis by quantifying turbulence production using 4D Flow MRI. Sci Rep (2017) 0.75

The Value and Limitations of Guidelines, Expert Consensus, and Registries on the Management of Patients with Thoracic Aortic Disease. Korean J Thorac Cardiovasc Surg (2016) 0.75

Experimental in vivo and ex vivo models for the study of human aortic dissection: promises and challenges. Am J Transl Res (2016) 0.75

Aortic dissection in women during the course of pregnancy or puerperium: a report of 11 cases in central south China. Int J Clin Exp Med (2015) 0.75

Two-dimensional speckle-tracking echocardiography for evaluation of dilative ascending aorta biomechanics. BMC Cardiovasc Disord (2017) 0.75

Follow-up after the Ross procedure, how significant it is, case reports of three patients. J Cardiothorac Surg (2015) 0.75

[Aneurysm of the thoracic aorta of traumatic origin: a suspected clinical case]. Pan Afr Med J (2015) 0.75

Identification of the main determinants of abdominal aorta size: a screening by Pocket Size Imaging Device. Cardiovasc Ultrasound (2017) 0.75

Chronic Type A Aortic Dissection: Two Cases and a Review of Current Management Strategies. Aorta (Stamford) (2016) 0.75

Differential aspects of the disease and treatment of Thoracic Acute Aortic Dissection (TAAD)-the European experience. Ann Cardiothorac Surg (2016) 0.75

Proportion of patients in the Uganda rheumatic heart disease registry with advanced disease requiring urgent surgical interventions. Afr Health Sci (2015) 0.75

Primary Percutaneous Coronary Intervention in Chronic Type A Aortic Dissection. Aorta (Stamford) (2016) 0.75

Transient Aortic Intramural Hematoma Complicating Transaortic Valve Replacement. Aorta (Stamford) (2016) 0.75

Regional and directional compliance of the healthy aorta: an ex vivo study in a porcine model. Interact Cardiovasc Thorac Surg (2016) 0.75

Hybrid treatment of a true thyreocervical trunk aneurysm in a patient with Type B aortic dissection. Ann Card Anaesth (2016) 0.75

Aetiology and management of hereditary aortopathy. Nat Rev Cardiol (2017) 0.75

Impact of admission serum total cholesterol level on in-hospital mortality in patients with acute aortic dissection. Pak J Med Sci (2016) 0.75

Chest pain: coronary CT in the ER. Br J Radiol (2016) 0.75

Major themes for 2014 in cardiothoracic and vascular anaesthesia and intensive care. Heart Lung Vessel (2015) 0.75

Arterial stiffness in hematologic malignancies. Onco Targets Ther (2017) 0.75

Altered aortic 3D hemodynamics and geometry in pediatric Marfan syndrome patients. J Cardiovasc Magn Reson (2017) 0.75

Imaging Surveillance After Proximal Aortic Operations: Is it Necessary? Ann Thorac Surg (2016) 0.75

Continuous measurement of aortic dimensions in Turner syndrome: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson (2017) 0.75

Clinical recognition of acute aortic dissections: insights from a large single-centre cohort study. Neth Heart J (2016) 0.75

Association between abdominal aortic plaque and coronary artery disease. Clin Interv Aging (2016) 0.75

Preoperative Predictors of Long-Term Mortality after Elective Endovascular Aneurysm Repair for Abdominal Aortic Aneurysm. Ann Vasc Dis (2016) 0.75

Differentially expressed genes and canonical pathways in the ascending thoracic aortic aneurysm - The Tampere Vascular Study. Sci Rep (2017) 0.75

Endovascular Repair of Aortic Dissection in Marfan Syndrome: Current Status and Future Perspectives. Diseases (2015) 0.75

Pathogenic Mechanisms of Bicuspid Aortic Valve Aortopathy. Front Physiol (2017) 0.75

Comparison of arterial stiffness/compliance in the ascending aorta and common carotid artery in healthy subjects and its impact on left ventricular structure and function. Int J Cardiovasc Imaging (2016) 0.75

Suture Line Dehiscence after Endovascular Aneurysm Repair in a Patient with Marfan Syndrome. Ann Vasc Dis (2017) 0.75

Aortic events in a nationwide Marfan syndrome cohort. Clin Res Cardiol (2016) 0.75

Genetic diagnostics of inherited aortic diseases : Medical strategy analysis. Herz (2017) 0.75

Perioperative cerebrospinal fluid drainage for the prevention of spinal ischemia after endovascular aortic repair. Gefasschirurgie (2017) 0.75

Ascending aorta reinterventions. J Thorac Dis (2017) 0.75

Enlightenment from a small but rapidly evolving penetrating aortic ulcer. Int J Cardiovasc Imaging (2016) 0.75

Usefulness of the echocardiographic paravertebral approach for the diagnosis of descending thoracic aortic dissection. J Echocardiogr (2017) 0.75

Unwarranted Variation in the Quality of Care for Patients With Diseases of the Thoracic Aorta. J Am Heart Assoc (2017) 0.75

A novel approach for local abdominal aortic aneurysm growth quantification. Med Biol Eng Comput (2016) 0.75

Safety and Necessity of Antiplatelet Therapy on Patients Underwent Endovascular Aortic Repair with Both Stanford Type B Aortic Dissection and Coronary Heart Disease. Chin Med J (Engl) (2017) 0.75

Secondary Open Aortic Procedure Following Thoracic Endovascular Aortic Repair: Meta-Analytic State of the Art. J Am Heart Assoc (2017) 0.75

The Genetics of Aortopathies in Clinical Cardiology. Clin Med Insights Cardiol (2017) 0.75

Aortic intramural hemorrhage: A distinct disease entity with mystery. Intractable Rare Dis Res (2017) 0.75

Articles by these authors

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09

2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J (2012) 16.00

Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr (2009) 14.63

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J (2011) 13.10

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73

Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J (2009) 11.90

Universal definition of myocardial infarction. Circulation (2007) 11.69

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet (2003) 11.67

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09

Guidelines on the management of valvular heart disease (version 2012). Eur Heart J (2012) 10.70

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail (2012) 10.38

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med (2008) 10.03

2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J (2014) 9.73

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA (2006) 9.27

Guidelines on myocardial revascularization. Eur Heart J (2010) 8.85

Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J (2003) 8.51

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J (2008) 8.20

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J (2004) 7.84

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 7.75

Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J (2007) 7.34

Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet (2013) 7.03

ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J (2010) 6.45

MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation (2007) 6.41

Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol (2009) 6.41

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace (2010) 6.31

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J (2013) 6.17

Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet (2004) 6.15

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10

Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med (2015) 6.00

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J (2006) 5.79

Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg (2012) 5.49

Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med (2014) 5.47

Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol (2002) 5.41

Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery. N Engl J Med (2002) 5.24

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J (2013) 5.23

ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J (2011) 5.11

Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr (2009) 4.69

Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J (2005) 4.62

Lyme borreliosis. Lancet Infect Dis (2003) 4.58

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J (2011) 4.47

NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. J Biol Chem (2004) 4.37

Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation (2004) 4.23

2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J (2015) 4.23

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13

Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol (2008) 4.12

Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet (2009) 4.10

Statins and the risk of cancer after heart transplantation. Circulation (2012) 4.06

Feasibility of low-dose coronary CT angiography: first experience with prospective ECG-gating. Eur Heart J (2007) 4.03

Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation (2006) 3.99

Partial thrombosis of the false lumen in patients with acute type B aortic dissection. N Engl J Med (2007) 3.92

Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. N Engl J Med (2016) 3.88

Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med (2008) 3.85

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J (2016) 3.83

Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation (2010) 3.79

Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation (2012) 3.70

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med (2005) 3.60

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J (2013) 3.58

Guidelines on myocardial revascularization. Eur J Cardiothorac Surg (2010) 3.47

European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2003) 3.43

Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet (2003) 3.40

Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation (2012) 3.39

Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction. Circulation (2011) 3.38

Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am Heart J (2002) 3.35

Update on myocardial bridging. Circulation (2002) 3.29